Notifications
Back

ABOUT US

Company introduction
CI

CEO Message∙



We contribute to a healthy life through innovative technology.

BioPOA Co., Ltd. is a specialized veterinary vaccine company

that designs and synthesizes viral genes using reverse genetics technology to develop and manufacture vaccines.


We aim to become a global biopharmaceutical leader by developing and commercializing reverse genetics technologies. 


A future shared by animals and humans,
we protect animal health with our own technology.


Over 20 Years of Virus Research Based on Molecular Biology


BioPOA Co., Ltd. is dedicated to transparent and honest management, bold and continuous R&D investment,

and driven by excellent technology and passionate talent.


 We will continue to innovate,

contributing to the advancement of biopharmaceuticals

and promoting both human and animal health — One Health.


CEO Sunhee Cho



DVM, College of Veterinary Medicine, Seoul National University

M.S., Veterinary Microbiology, Seoul National University

Ph.D., Veterinary Microbiology, Seoul National University


1994 KIST, Genetic Engineering Lab 

– Molecular Biology & Viral Epidemiology

1995 Cancer Research Institute, SNU Medical School

– Tumor Vaccine Development

1996 Mogam Institute (GC Pharma) – DNA Vaccine Development

2001 Intron Bio – Molecular Diagnostics, Phage/Vaccine Development

2007 CEO, BioPOA – Vaccine Development


Company History∙



2021~Present

"Reverse genetics technology for

PRRS virus vaccine development"

2025

  • Jan  First export of PoaVac PRRS live vaccine (Cambodia, Thailand)
  • Aug  PoaVac Gumboro Live Vaccine approved

2024

  • Jul  Pre-IPO investment secured

2022

  • Mar  Preliminary technology assessment by NICE D&B – Rated “A”
  • Jul  Certified NeT New Technology (Reverse genetics SAVE for PRRS vaccine)
  • Oct  PoaVac PRRS technology transfer agreement signed (CEVA)
  • Nov  INNO-Biz “AA” certification (Innovative SME)

2021

  • Jan  First overseas export of COVID-19 diagnostic kit PoaCheck (Uzbekistan)
  • Apr  PoaVac PRRS Live Vaccine approved
  • Oct  KVGMP certification : biologicals (viral vaccine)
  • Nov  National LOT Release for PoaVac PRRS
2011~2020

"Creating a better future for all"

2020

  • May  KVGMP certification (embryonated egg-based vaccine)
  • Jun  Selected as an Animal Drug Testing Institution
  • Aug  IPO underwriter selected
  • Aug  Licensed for in-vitro diagnostic medical devices and CE certification
  • Aug  Export license for PoaCheck diagnistic kit 
  • Dec  Investment from Harim Group’s Korea Thumb Vet corp.

2018

  • Apr  Relocated to new headquarters in Hwaseong
  • Sep  Second round investment from Yuhan Corporation

2017

  • Mar  Investment from Yuhan Corporation

2016

  • May  VC institutional investment secured


2005~2010

"Biopoa’s passionate journey begins"

2010

  • Nov  Designated livestock disease diagnosis institution (APQA)

2009

  • Aug  Established corporate R&D center and LMO research facility

2008

  • Jan  Investment from JOIN Agricultural Corporation 
  • Feb  The world's first development and commercialization of an antigen-specific NDV vaccine using reverse genetics technology 
  • Nov  Certified as a venture business

2007 

  • Feb  BioPOA Co., Ltd. founded; Sunhee Cho appointed as CEO

2005

  • Sep  Joined startup incubator at Seoul National University, College of Agriculture and Life Sciences
  • Dec  Certified as a preliminary venture business

CI∙

Symbol Mark
BioPharmaceuticals + State Of the Art

The BioPOA symbol integrates the initials B and P from the company’s English name,

along with visual elements representing DNA and biotechnology.

This design conveys BioPOA’s identity as a biopharmaceutical company in a refined and minimalist way.


Color regulations

Location Guide∙



Address
  593-26, Dongtangiheung-ro, Hwaseong-si, Gyeonggi-do, Republic of Korea
Contact
  Tel: +82-31-375-8304
Public Transportation Directions
  •   From Byeongjeom Station: Board Bus No. 708 or 712 at Byeongjeom Station Intersection → Get off at Prugio / Hanmi Pharmaceutical → Walk 532m to BioPOA
  •   From Dongtan Station: Board Bus No. H1 at Dongtan Station (East Exit) → Get off at Prugio / Hanmi Pharmaceutical → Walk 508m to BioPOA
  •   From Gangnam Station: Board Bus No. 6004 at Sinnonhyeon Station, Yeongshin Building → Get off at Prugio / Hanmi Pharmaceutical → Walk 532m to BioPOA
  •  From Seoul Station: Board Bus No. M4108 at Seoul Station Bus Transfer Center Stop 6 → Transfer to Bus No. 708 at Yedang Village / Lotte Castle (Center) → Get off at Prugio / Hanmi Pharmaceutical → Walk 532m to BioPOA

About Us              Privacy Policy              Terms of Use